Search

Displaying results 4351 - 4360 of 5040 in total
  1. Drug

    Alnespirone

    go.drugbank.com/drugs/DB19784
    Experimental

    Alnespirone has a monoisotopic molecular weight of 442.28 Da.

  2. Drug

    Eptapirone

    go.drugbank.com/drugs/DB19836
    Experimental

    Eptapirone has a monoisotopic molecular weight of 345.19 Da.

  3. Drug

    Nifurprazine

    go.drugbank.com/drugs/DB20175
    Experimental

    Nifurprazine has a monoisotopic molecular weight of 232.06 Da.

  4. Drug

    Sulukast

    go.drugbank.com/drugs/DB20934
    Experimental

    Sulukast has a monoisotopic molecular weight of 472.25 Da.

  5. Drug

    Ledaborbactam

    go.drugbank.com/drugs/DB21457
    Experimental

    Ledaborbactam has a monoisotopic molecular weight of 263.1 Da.

  6. Drug

    Xininurad

    go.drugbank.com/drugs/DB21564
    Experimental

    Xininurad has a monoisotopic molecular weight of 440.91 Da.

  7. Drug

    Ansornitinib

    go.drugbank.com/drugs/DB21577
    Experimental

    Ansornitinib has a monoisotopic molecular weight of 540.25 Da.

  8. Drug

    Garsorasib

    go.drugbank.com/drugs/DB21581
    Investigational

    Garsorasib has a monoisotopic molecular weight of 598.26 Da.

  9. Drug

    Odentegravir

    go.drugbank.com/drugs/DB21708
    Experimental

    Odentegravir has a monoisotopic molecular weight of 421.12 Da.

  10. Drug

    Posizolid

    go.drugbank.com/drugs/DB04850
    Investigational

    In July 2002, after completion of phase I trials in December 2001, AstraZeneca announced that they were no longer pursuing the development of Posizolid, presumably due to negative trial results (though